Weekly treatment with a combination of bortezomib and bendamustine in relapsed or refractory indolent non-Hodgkin lymphoma. [electronic resource]
Producer: 20100402Description: 149-52 p. digitalISSN:- 1029-2403
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bendamustine Hydrochloride
- Boronic Acids -- administration & dosage
- Bortezomib
- Cohort Studies
- Drug Administration Schedule
- Female
- Humans
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Nitrogen Mustard Compounds -- administration & dosage
- Protease Inhibitors -- administration & dosage
- Pyrazines -- administration & dosage
- Recurrence
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Letter
There are no comments on this title.
Log in to your account to post a comment.